Heart failure is a complex, progressive syndrome that can be challenging to manage.1,2 It is associated with a markedly poor prognosis and significantly reduced quality of life, leading to increased risk of death.1,2
From preventing heart-failure–related hospitalization to improving quality of life and extending survival, clinicians play a critical role in identifying heart failure progression early enough to make a significant difference in patients’ lives.
It’s important to recognize when medications alone are not enough, and advanced therapies need to be considered.2
In New York Heart Association (NYHA) Class II heart failure, cardiac resynchronization therapy may be appropriate.7
As disease progresses to NYHA Class III, actionable, remote measurement of pulmonary arterial pressure is proven to reduce heart failure hospitalizations and mortality.8,9
Triggers for consideration of LVAD Therapy:10
i. Persistently high PA pressures
ii. Non-responsive to diuretics or neurohormonal agents
iii. 6 MWD < 300 m
iv. Heart failure hospitalizations
v. ECHO exam unchanged
Clinicians play a critical role in identifying heart failure progression early enough to help prevent heart failure-related hospitalizations, improve quality of life and extend survival for patients.
Even with optimal medical management, medications can become less effective as heart failure progresses. It’s important to recognize when medications alone are not enough, and advanced therapies need to be considered.2
Fortunately, continuous innovation is creating more options for patients with advanced heart failure, offering more hope for better lives.
MAT-2106646 v2.0
You are about to enter an Abbott country- or region-specific website.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions
Do you wish to continue and enter this website?
MAT-2305078 v1.0
